Researchers say vaccine appears to 'mop up' leukaemia cells Gleevec leaves behind
Monday, January 11, 2010 - 11:00
in Health & Medicine
Johns Hopkins Kimmel Cancer Centre researchers say preliminary studies show that a vaccine made with leukaemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukaemia (CML) patients taking the drug Imatinib mesylate (Gleevec)...